Citation tools
"A radiomic biomarker characterizing tumor dissemination in patients has complementary predictive value to metabolic tumor volume in a large cohort of diffuse large B-cell lymphoma patients responding to R-CHOP treatment." Journal of Nuclear Medicine
61.supplement 1
(2020):
270.
Web. 19 April. 2024.